LSM1 and metastatic neoplasm: As PC is regularly diagnosed at advanced clinical stages, with over 50% of patients presenting with metastatic disease,1 we evaluated whether CaSm overexpression, which is believed to occur early in neoplastic progression, contributes to cellular migration and invasion.